Ibáñez Raquel, Roura Esther, Morey Francisca, Andújar Miguel, Pavón Miquel Ángel, Acera Amelia, Bruni Laia, de Sanjosé Silvia
Cancer Epidemiology Research Programme, Catalan Institute of Oncology-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
Cancers (Basel). 2024 Dec 29;17(1):63. doi: 10.3390/cancers17010063.
: Implementing self-sampling (SS) in cervical cancer screening requires comparable results to clinician-collected samples (CCS). Agreement measures are essential for evaluating HPV test performance. Previous studies on non-paired samples have reported higher viral cycle threshold (Ct) values in SS compared to CCS, affecting sensitivity for detecting cervical intraepithelial neoplasia grade 2 or worse (CIN2+). We aimed to evaluate the agreement of high-risk (hr)HPV testing results between SS and CCS using paired samples and to explore differences in Ct values. : Women aged 30 to 65 years attending cervical cancer screening in two regions of Spain were invited to participated in this study. For each woman there was: CCS collected during the screening visit using liquid-based cytology and cytobrush, and a SS using a brush at home one month later. A PCR-based assay was used for hrHPV detection. Agreement in hrHPV results among both samples, Ct value differences, and their association with screening outcomes were analyzed. : This study included 981 women with paired samples. SS had a higher hrHPV prevalence than CCS (overall ratio of 1.3). Positive agreement for all hrHPV genotypes, HPV16, HPV18, and other hrHPV types were 85%, 91.3%, 66.7%, and 83.3%, respectively. Negative agreement was >95% for all results. Median Ct values was slightly higher in SS than in CSS (32.9 vs. 30.6, = 0.02). Seven CIN2+ cases HPV positive were detected by both methods. One CIN3 case was missed by SS. : This study showed a good agreement between SS and CCS for hrHPV testing in a routine screening in Spain. Despite the slightly higher Ct values for SS, no significant impact on sensitivity could be determined due to the low incidence of CIN2+ cases. Further research on larger paired samples is needed to assess the implications of Ct values on test sensitivity.
在宫颈癌筛查中实施自我采样(SS)需要与临床医生采集的样本(CCS)取得可比的结果。一致性测量对于评估人乳头瘤病毒(HPV)检测性能至关重要。以往对非配对样本的研究报告称,与CCS相比,SS中的病毒循环阈值(Ct)值更高,这影响了检测宫颈上皮内瘤变2级或更严重病变(CIN2+)的敏感性。我们旨在使用配对样本评估SS和CCS之间高危(hr)HPV检测结果的一致性,并探讨Ct值的差异。:邀请西班牙两个地区参加宫颈癌筛查的30至65岁女性参与本研究。对于每位女性,有:在筛查就诊期间使用液基细胞学和细胞刷采集的CCS,以及一个月后在家中使用刷子进行的SS。采用基于聚合酶链反应(PCR)的检测方法进行hrHPV检测。分析了两个样本之间hrHPV结果的一致性、Ct值差异及其与筛查结果的关联。:本研究纳入了981名有配对样本的女性。SS的hrHPV患病率高于CCS(总体比率为1.3)。所有hrHPV基因型、HPV16、HPV18和其他hrHPV类型的阳性一致性分别为85%、91.3%、66.7%和83.3%。所有结果的阴性一致性均>95%。SS中的Ct值中位数略高于CSS(32.9对30.6,P = 0.02)。两种方法均检测到7例HPV阳性的CIN2+病例。SS漏检了1例CIN3病例。:本研究表明,在西班牙的常规筛查中,SS和CCS在hrHPV检测方面具有良好的一致性。尽管SS的Ct值略高,但由于CIN2+病例的低发病率,无法确定对敏感性有显著影响。需要对更大的配对样本进行进一步研究,以评估Ct值对检测敏感性的影响。